This week's View discusses the PRAGUE-18 (Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction) trial and summarizes two articles from the Journal of the American College of Cardiology: one on the application of human embryonic stem cells in left ventricular dysfunction and one on the use of antithrombotic therapy in peripheral artery disease.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Vascular Medicine, Atherosclerotic Disease (CAD/PAD), Anticoagulation Management and ACS

Keywords: Myocardial Infarction, Stem Cells, Ventricular Dysfunction, Left, Peripheral Arterial Disease, Fibrinolytic Agents, Acute Coronary Syndrome, Anticoagulants, EaglesEyeView

< Back to Listings